Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00361_DB01097_nanopub.RASNM-v1qJwrtqNgbZwNRxa808vgAsUibFd2f63D0v7lg#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00361_DB01097 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00361_DB01097 label "DDI between Vinorelbine and Leflunomide - Vinorelbine may increase the adverse/toxic effects of Leflunomide. This may increase the risk of hematologic toxicities such as pancytopenia, agranulocytosis and thrombocytopenia. In patients receiving Vinorelbine, consider eliminating the loading dose of Leflunomide. Monitor for bone marrow suppression at least monthly during concomitant therapy. [drugbank_resource:DB00361_DB01097]" assertion.
- drugbank_resource:DB00361_DB01097 identifier "drugbank_resource:DB00361_DB01097" assertion.
- drugbank_resource:DB00361_DB01097 title "DDI between Vinorelbine and Leflunomide - Vinorelbine may increase the adverse/toxic effects of Leflunomide. This may increase the risk of hematologic toxicities such as pancytopenia, agranulocytosis and thrombocytopenia. In patients receiving Vinorelbine, consider eliminating the loading dose of Leflunomide. Monitor for bone marrow suppression at least monthly during concomitant therapy." assertion.
- drugbank:DB00361 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00361_DB01097 assertion.
- drugbank:DB01097 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00361_DB01097 assertion.